Latest Announcements

Alembic Pharmaceuticals Limited reported its consolidated financial results for the first quarter and year ended 30th June 2026. Revenue from operations increased by 26% YoY to Rs.2150 Cr. Profit After Tax at Rs. 173 Cr, up 12% YoY. EBITDA pre R&D increased to Rs. 523 Cr; margin stood at 24%. The company has started FY27 on a strong note, delivering broad-based growth across its businesses.

Suzlon Energy Limited has informed the Exchange about the Transcript of Q1 FY27 Earnings Conference Call, which is available on the company's website (www.suzlon.com).

Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation on Unaudited Financial Results for the quarter ended 30th June, 2026. The presentation highlights a 26% YoY growth in revenue, with key highlights including a 7% YoY growth in India Branded Business, 49% YoY growth in US Formulation, and 33% YoY growth in R&D. The company also reported a 33% YoY growth in PAT, supported by a strong order book.

Alembic Pharmaceuticals Limited has submitted its financial results for the quarter ended June 30, 2026, with the Board of Directors approving the consolidated and standalone unaudited financial results along with the Limited Review Report issued by the Statutory Auditors.

Wonderla Holidays Limited has submitted its financial results for the quarter ended June 30, 2026, with a profit before tax of Rs. 9,346.54 lakhs and a total revenue of Rs. 25,210.21 lakhs. The company has also allotted 15,105 shares to employees and granted 8,980 stock options to two employees.

Repro India Limited has informed the Exchange about Investor Presentation, showcasing Q1 FY27 performance highlights, including 20% YoY revenue growth, stable gross margins, and exceptional gain from Mahape land sale.

Emami Limited reported a 15% topline growth in Q1FY27, with consolidated revenues reaching ₹1,039 crore. Domestic Business grew 20%, while International Business declined 12% due to West Asia disruptions. EBITDA grew 6% to ₹226 crore despite higher input costs.

Emami Limited has reported a 15% topline growth in Q1FY27, with domestic business growing 20% and international business declining 12% due to West Asia disruptions. The company has also made strategic investments to strengthen its future growth portfolio.

Morepen Laboratories Limited has announced its financial results for Q1 FY27, reporting its highest-ever quarterly revenue and earnings, supported by better operating leverage, improved performance on API front, strong export growth and full scale commercialization of CDMO mandate.

Capillary Technologies India Limited has acquired the CustomerGlu software platform and associated intellectual property from Marax AI, Inc. through an asset purchase agreement.

Patel Retail Limited has expanded its distribution network for its flagship brand 'Indian Chaska' by entering Madhya Pradesh, strengthening its domestic market presence.

Indian Metals & Ferro Alloys Ltd (IMFA) reported record revenue and robust financial performance in Q1 FY27, driven by higher ferro chrome output and firm prices. The company's Greenfield Expansion Project at Kalinganagar is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. IMFA has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, expected to be available by June 2027.

Dr. Agarwal's Health Care Limited announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations growing by 26.0% YoY to ₹614 Crores, total income growing by 23.9% YoY to ₹620 Crores, IND-AS EBITDA growing by 25.2% YoY to ₹177 Crores, and PAT growing by 44.6% YoY to ₹55 Crores.

Indian Metals & Ferro Alloys Ltd (IMFA) has announced its Q1 FY2027 earnings, reporting a record revenue of ₹960.45 crore, up 50% from ₹641.54 crore in Q1 FY26, driven by higher ferro chrome output and firm prices. The company's EBITDA and PAT also saw significant increases, to ₹281.27 crore and ₹191.49 crore, respectively. IMFA's Greenfield Expansion Project at Kalinganagar (KNR 1) is on track, with the first furnace expected to be commissioned in August 2026 and the second furnace in September 2026. The company has also signed a long-term offtake arrangement with Enfinity Global for an additional 65 MWp hybrid renewable energy, which will contribute to its green footprint.

Capillary Technologies India Limited has announced its financial results for the first quarter ended June 30, 2026, with a 43% year-on-year growth in operating revenue and a 132% year-on-year growth in adjusted EBITDA. The company reported strong profitability metrics with normalized profit after tax (PAT) growing exponentially (+3,320%) driven by operational efficiencies and integration synergies across the acquired businesses.

Belrise Industries Limited has informed the Exchange about Investor Presentation regarding the acquisition of India Tipper Body business from Hyva (India) Pvt.Ltd. through a Business Transfer Agreement. The acquisition is expected to strengthen Belrise's position as a Tier-0.5 supplier and add a leading European commercial vehicle OEM to its customer base. The estimated EBITDA for CY251 is ₹11.91 crores with a ROCE of 1.57 and a purchase consideration of ₹5.65 crores.

Belrise Industries Limited has acquired the Tipper Body Business of Hyva (India) Pvt. Ltd. for approximately USD 5.65 million, strengthening its position as a Tier-0.5 supplier in the commercial vehicle ecosystem.

TruAlt Bioenergy Limited has informed the Exchange about the transcript of Earnings Conference Call held on July 29, 2026, to discuss the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

RITES Limited has informed the Exchange that Record date for the purpose of first interim Dividend for the FY 2026-27 is 10-Aug-2026. The company has declared an interim dividend of ₹ 1.40 per share (14% of paid-up share capital) for the financial year 2026-27. The Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended on 30th June, 2026, along with Limited Review Reports thereon are enclosed herewith.

Supreme Petrochem Limited has announced its Q1 FY27 earnings, with revenue from operations at INR 1693 crores, a 22% year-on-year growth, driven by a significant increase in raw material prices due to conflict in West Asia. The company's operating EBITDA stood at INR 331 crores, with a strong growth of 188% year-on-year, and net profit after tax was at INR 236 crores.